M J E Mourits

900 total citations
10 papers, 551 citations indexed

About

M J E Mourits is a scholar working on Genetics, Pathology and Forensic Medicine and Reproductive Medicine. According to data from OpenAlex, M J E Mourits has authored 10 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Pathology and Forensic Medicine and 4 papers in Reproductive Medicine. Recurrent topics in M J E Mourits's work include BRCA gene mutations in cancer (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Genetic factors in colorectal cancer (3 papers). M J E Mourits is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Genetic factors in colorectal cancer (3 papers). M J E Mourits collaborates with scholars based in Netherlands. M J E Mourits's co-authors include Joanne A. de Hullu, Ate G.J. van der Zee, R.H.M. Verheijen, H. Hollema, J.G. Aalders, D.A. Piers, Geertruida H. de Bock, Elisabeth G.E. de Vries, W.J. Sluiter and Klaske A. ten Hoor and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Maturitas.

In The Last Decade

M J E Mourits

10 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M J E Mourits Netherlands 8 215 185 175 174 143 10 551
Astrid Baalbergen Netherlands 14 312 1.5× 117 0.6× 212 1.2× 240 1.4× 113 0.8× 24 601
Sergei Zehavi Israel 11 140 0.7× 54 0.3× 189 1.1× 44 0.3× 56 0.4× 19 417
David M. Gershenson United States 12 171 0.8× 34 0.2× 351 2.0× 39 0.2× 65 0.5× 16 530
Ingeborg B. Engelsen Norway 11 343 1.6× 69 0.4× 145 0.8× 26 0.1× 84 0.6× 14 533
Jennifer Ducie United States 13 436 2.0× 49 0.3× 409 2.3× 120 0.7× 81 0.6× 16 630
Jack Basil United States 7 77 0.4× 59 0.3× 96 0.5× 31 0.2× 53 0.4× 17 257
Maria J. Baker United States 10 29 0.1× 137 0.7× 21 0.1× 73 0.4× 120 0.8× 19 476
Ali Kucukmetin United Kingdom 13 346 1.6× 22 0.1× 254 1.5× 133 0.8× 138 1.0× 29 531
Justine M. Briët Netherlands 7 349 1.6× 84 0.5× 261 1.5× 46 0.3× 50 0.3× 10 440
Chulmin Lee South Korea 12 277 1.3× 26 0.1× 190 1.1× 86 0.5× 41 0.3× 26 407

Countries citing papers authored by M J E Mourits

Since Specialization
Citations

This map shows the geographic impact of M J E Mourits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M J E Mourits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M J E Mourits more than expected).

Fields of papers citing papers by M J E Mourits

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M J E Mourits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M J E Mourits. The network helps show where M J E Mourits may publish in the future.

Co-authorship network of co-authors of M J E Mourits

This figure shows the co-authorship network connecting the top 25 collaborators of M J E Mourits. A scholar is included among the top collaborators of M J E Mourits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M J E Mourits. M J E Mourits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bock, Geertruida H. de, et al.. (2010). Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers. Maturitas. 66(3). 310–314. 24 indexed citations
2.
Mourits, M J E & Geertruida H. de Bock. (2009). Managing hereditary ovarian cancer. Maturitas. 64(3). 172–176. 17 indexed citations
3.
Hermsen, Brenda, R.I. Olivier, René H.M. Verheijen, et al.. (2007). No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study. British Journal of Cancer. 96(9). 1335–1342. 104 indexed citations
4.
Bock, Geertruida H. de, M J E Mourits, Mieke Schutte, et al.. (2006). Association between the CHEK2*1100delC germ line mutation and estrogen receptor status. International Journal of Gynecological Cancer. 16(s2). 552–555. 17 indexed citations
5.
Mourits, M J E & Geertruida H. de Bock. (2006). Exogenous steroids for menopausal symptoms and breast/endometrial cancer risk. International Journal of Gynecological Cancer. 16(s2). 494–496. 7 indexed citations
6.
Mourits, M J E, A. G. van der Zee, P.H.B. Willemse, Harry Hollema, & Elisabeth G.E. de Vries. (2003). [The effects of tamoxifen on the female genital tract].. PubMed. 147(47). 2315–20. 3 indexed citations
7.
Mourits, M J E, Elisabeth G.E. de Vries, A. G. van der Zee, et al.. (2002). Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy. British Journal of Cancer. 86(10). 1546–1550. 60 indexed citations
8.
Hullu, Joanne A. de, H. Hollema, D.A. Piers, et al.. (2000). Sentinel Lymph Node Procedure Is Highly Accurate in Squamous Cell Carcinoma of the Vulva. Journal of Clinical Oncology. 18(15). 2811–2816. 263 indexed citations
9.
Mourits, M J E, Elisabeth G.E. de Vries, Pax H.B. Willemse, et al.. (1999). Ovarian cysts in women receiving tamoxifen for breast cancer. British Journal of Cancer. 79(11-12). 1761–1764. 46 indexed citations
10.
Berends, Maran J.W., Jan H. Kleibeuker, Elisabeth G.E. de Vries, et al.. (1999). The importance of family history in young patients with endometrial cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 82(2). 139–141. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026